Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Morphinans Stories

2013-12-14 23:02:59

A Toledo treatment center is adding programs toward getting people free from drug and alcohol dependency. Call (855) 912-7867 for an appointment at Drug Addiction Treatment Centers. Toledo, OH (PRWEB) December 14, 2013 A Toledo treatment center is announcing a new initiative that would help decrease the number of drug-related deaths in Ohio through the help and support available at Drug Addiction Treatment Centers. Based upon statistical data, drug overdose deaths continue to be a public...

2013-12-12 08:31:03

~ National Nonprofit Launches Innovative Tool to Help Parents Understand Lifesaving Benefits of Medication-Assisted Treatment for Opiate Addiction ~ NEW YORK, Dec. 12, 2013 /PRNewswire-USNewswire/ -- The Partnership at Drugfree.org, a national nonprofit working to find evidence-based solutions to adolescent substance use, today launched a comprehensive new digital resource that helps parents better understand the potential life-saving benefits of medication-assisted treatment. The...

2013-12-11 08:31:39

Pending US FDA Approval, Expected Product Launch with Actavis in Second Half of 2014 SYDNEY and BEDMINSTER, N.J., Dec. 11, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May 2014 as the new Prescription Drug User Fee Act (PDUFA) date for action on the Company's refiled New Drug Application (NDA) for immediate release MOXDUO. The FDA will schedule an Advisory Committee...

2013-12-10 23:34:35

New non-addictive opiate withdrawal supplement backed by scientific research and personal experiences starts working with the first dose. Boca Raton, Fla (PRWEB) December 10, 2013 With opiate addiction now a national epidemic, more people than ever are looking for a less painful way to detox, break the addiction cycle and move on with far happier lives. Today, Sunrise Nutraceuticals is pleased to announce the nationwide release of Elimidrol, a revolutionary new opiate withdrawal support...

2013-12-10 16:24:48

ALISO VIEJO, Calif., Dec. 10, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint. (Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO) In the PRIME study, AVP-923 treated patients experienced levels of pain...

2013-12-09 23:01:51

US News reports that new research is granting an insight into how heroin addiction changes the brain and offers potential treatments for the future. Harbor Village is excited by the way this may change how heroin addiction is treated. Miami, FL (PRWEB) December 09, 2013 A recent study has found that for people who use heroin over a long period of time, changes have been seen in the genes that determine brain function. As changes to a genetic structure tend to be permanent, it is important...

2013-12-06 23:03:13

According to George Catlin of Withdrawal Ease, the FDA's new restrictions on painkillers are not without risk. Austin, TX (PRWEB) December 06, 2013 In an effort to combat the growing problem of prescription drug abuse, the FDA announced it will begin recommending tighter controls on how doctors prescribe commonly used narcotic painkillers that contain Hydrocodone. For those that have witnessed the destruction of painkiller abuse firsthand, this is welcome news. But according to...

2013-12-05 04:21:04

FDA Reclassification of Hydrocodone to Schedule II Could Boost Sales. PALO ALTO, CA, Dec. 5, 2013 /PRNewswire/ - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that work on the name change to Praxsyn Corporation is nearing completion and that the Company expects to be able to file a request with FINRA early next week along with filing the necessary filings and disclosures with the SEC and the State of Illinois. Furthermore, the audit of Mesa Pharmacy, Inc.'s...

2013-12-04 16:25:35

NORTH LIBERTY, Iowa, Dec. 4, 2013 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D. will present at the Oppenheimer 24(th) Annual Healthcare Conference being held in New York City December 10-11, 2013. Among the topics to be discussed, Dr. Mickle will provide an overview of KP201, the company's lead clinical candidate...

2013-12-03 23:21:10

Waismann Method® rapid detox treatment offers hope to families in crisis Los Angeles, CA (PRWEB) December 03, 2013 In response to recent news, including the Payson Roundup news story that prescription drug abuse spikes heroin use, doctors and staff of the Waismann Method® rapid detox program, have been assisting patients that are caught in this escalating heroin epidemic in the U.S. Opiate abuse in general is at unprecedented levels in our country, and there have been sharp...